Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity.

Gómez-Gonzalo M, Benedicto I, Carretero M, Lara-Pezzi E, Maldonado-Rodríguez A, Moreno-Otero R, Lai MM, López-Cabrera M.

Virology. 2004 Oct 10;328(1):120-30.

2.

The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y.

Cell. 1996 Nov 29;87(5):953-9.

3.

Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.

Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F.

Virology. 2000 Nov 25;277(2):278-95.

5.

Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment.

Masumi A, Ozato K.

J Biol Chem. 2001 Jun 15;276(24):20973-80. Epub 2001 Apr 13.

6.

Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.

Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML, Koseki H, Kitabayashi I.

EMBO J. 2006 Sep 6;25(17):3955-65. Epub 2006 Aug 17.

7.

The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors.

Yahata T, de Caestecker MP, Lechleider RJ, Andriole S, Roberts AB, Isselbacher KJ, Shioda T.

J Biol Chem. 2000 Mar 24;275(12):8825-34.

8.

Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.

Lubyova B, Kellum MJ, Frisancho AJ, Pitha PM.

J Biol Chem. 2004 Feb 27;279(9):7643-54. Epub 2003 Dec 10.

9.

Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.

Oelgeschläger M, Janknecht R, Krieg J, Schreek S, Lüscher B.

EMBO J. 1996 Jun 3;15(11):2771-80.

10.

CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.

Kim JH, Cho EJ, Kim ST, Youn HD.

Nat Struct Mol Biol. 2005 May;12(5):423-8. Epub 2005 Apr 17.

PMID:
15834423
11.

A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1.

Saint Just Ribeiro M, Hansson ML, Wallberg AE.

Biochem J. 2007 Jun 1;404(2):289-98.

12.

The hepatitis B virus X protein binds to and activates the NH(2)-terminal trans-activation domain of nuclear factor of activated T cells-1.

Carretero M, Gómez-Gonzalo M, Lara-Pezzi E, Benedicto I, Aramburu J, Martínez-Martínez S, Redondo JM, López-Cabrera M.

Virology. 2002 Aug 1;299(2):288-300.

13.

CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.

Ait-Si-Ali S, Polesskaya A, Filleur S, Ferreira R, Duquet A, Robin P, Vervish A, Trouche D, Cabon F, Harel-Bellan A.

Oncogene. 2000 May 11;19(20):2430-7.

14.

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.

Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK.

J Biol Chem. 2004 Dec 3;279(49):51163-71. Epub 2004 Sep 20.

15.

CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation.

Avots A, Buttmann M, Chuvpilo S, Escher C, Smola U, Bannister AJ, Rapp UR, Kouzarides T, Serfling E.

Immunity. 1999 May;10(5):515-24.

16.
17.
18.

The Ewing's sarcoma gene product functions as a transcriptional activator.

Rossow KL, Janknecht R.

Cancer Res. 2001 Mar 15;61(6):2690-5.

19.

Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.

Vervoorts J, Lüscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M, Lüscher B.

EMBO Rep. 2003 May;4(5):484-90.

20.

p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively.

Gelman L, Zhou G, Fajas L, Raspé E, Fruchart JC, Auwerx J.

J Biol Chem. 1999 Mar 19;274(12):7681-8.

Supplemental Content

Support Center